MHRA updated its guidance on data integrity definitions and expectations for the pharmaceutical industry in mid-March. The guidance is meant to complement the EU GMP standards available in Eudralex. The update provides clarifications to the text following high levels of interest after its publication in late January.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
